Hospitals | April 14, 2026
Shalby Hospitals gets 5-year kidney transplant approval for Ahmedabad Krishna Unit
The license is valid for five years, effective from April 9, 2026
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
Integrated multidisciplinary model positions Hyderabad as a growing referral hub for advanced pediatric care
These surgeries involve no bone cuts, minimal surgical trauma, smaller incisions and significantly reduced blood loss
The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States
The approval now covers procedures using 10-14F inner diameter and up to 17F outer diameter procedural sheaths
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Hyderabad-based peptide specialist strengthens complex generics credentials as Apotex prepares for U.S. commercialization of semaglutide injection
The collaboration brings together AIG Hospitals’ high-volume clinical expertise, advanced innovation capabilities, and growing artificial intelligence-led healthcare initiatives
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Subscribe To Our Newsletter & Stay Updated
